French biotech gets funding for universal flu and coronavirus vaccines 09-Jul-2020 By Ben Hargreaves Osivax receives public funding to apply its vaccine technology to protect against COVID-19 and future coronavirus strains.
Rentschler and Vetter cooperate to integrate services 09-Jul-2020 By Ben Hargreaves The CDMOs will launch pilot projects to determine where collaboration may help streamline drug development.
Operation Warp Speed delivers $2bn to scale COVID-19 solutions 08-Jul-2020 By Ben Hargreaves Novavax is the principle recipient of the funding, as US government provides capital in return for guaranteed access to doses.
Emergent signs $480m, five-year vaccine deal with J&J 07-Jul-2020 By Ben Hargreaves Emergent will provide contract development and manufacturing services for J&J’s potential COVID-19 vaccine.
Regeneron COVID-19 antibody cocktail enters late-stage trials 07-Jul-2020 By Ben Hargreaves Regeneron’s potential coronavirus treatment enters Phase III and US government provides capital injection for manufacture.
Sarepta licenses therapy to boost gene therapies 06-Jul-2020 By Ben Hargreaves Sarepta signs agreement with Hansa to use its treatment as part of a gene therapy treatment schedule.
J&J receives EU approval for Ebola vaccine 06-Jul-2020 By Ben Hargreaves The company becomes the second to receive approval, behind Merck, for its Ebola vaccine.
Tesla’s ‘side project’ building RNA microfactories for CureVac 03-Jul-2020 By Ben Hargreaves Elon Musk revealed the news on Twitter that Tesla was working with CureVac and ‘possibly others’ to produce RNA vaccines.
Takeda expands in gene therapy with $900m R&D deal 02-Jul-2020 By Ben Hargreaves Takeda signs R&D agreement with Carmine for the development of two non-viral gene therapies.
Pfizer posts positive vaccine results and capacity for 1.2bn doses 02-Jul-2020 By Ben Hargreaves Pfizer and BioNTech release positive results from Phase I/II trials investigating their mRNA vaccine against COVID-19.
FDA says COVID-19 vaccine must be effective in half of recipients 01-Jul-2020 By Ben Hargreaves US FDA demands that vaccine must prevent or decrease severity in at least 50% of people receiving doses.
BioNTech receives $250m investment amid vaccine development 30-Jun-2020 By Staff Reporter June sees BioNTech secure hundreds of millions in investment to progress pipeline, including mRNA COVID-19 vaccine.
CSL Behring in $450m spend on hemophilia gene therapy 30-Jun-2020 By Ben Hargreaves The company buys the global rights to a gene therapy currently going through Phase III trials.
Inovio posts positive COVID-19 vaccine results but few details 30-Jun-2020 By Ben Hargreaves The biotech reveals positive results of Phase I trials but does not provide a fuller picture of data.
Stevanato partners with CEPI for 2 billion vaccine vials 29-Jun-2020 By Ben Hargreaves CEPI signs agreement for supply of glass vials to speed up COVID-19 vaccine development timeline.
